Clinical Trial Update: Fertility-sparing Management Using High-dose Oral Progestin in Young Women With Endometrial Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating fertility-sparing management using high-dose oral progestin in young women with endometrial cancer; current status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• oral progestin therapy (progestin)

Snippet

Sponsor: Asan Medical Center | Conditions: Endometrial Cancer | Phase 2 | Status: UNKNOWN